Cargando…
Genetically programmed changes in transcription of the novel progranulin regulator
ABSTRACT: Progranulin is a glycoprotein marking chronic inflammation in obesity and type 2 diabetes. Previous studies suggested PSRC1 (proline and serine rich coiled-coil 1) to be a target of genetic variants associated with serum progranulin levels. We aimed to identify potentially functional varia...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399677/ https://www.ncbi.nlm.nih.gov/pubmed/32620998 http://dx.doi.org/10.1007/s00109-020-01942-7 |
_version_ | 1783566189286391808 |
---|---|
author | Keller, Maria Gebhardt, Claudia Huth, Sandra Schleinitz, Dorit Heyne, Henrike Scholz, Markus Stumvoll, Michael Böttcher, Yvonne Tönjes, Anke Kovacs, Peter |
author_facet | Keller, Maria Gebhardt, Claudia Huth, Sandra Schleinitz, Dorit Heyne, Henrike Scholz, Markus Stumvoll, Michael Böttcher, Yvonne Tönjes, Anke Kovacs, Peter |
author_sort | Keller, Maria |
collection | PubMed |
description | ABSTRACT: Progranulin is a glycoprotein marking chronic inflammation in obesity and type 2 diabetes. Previous studies suggested PSRC1 (proline and serine rich coiled-coil 1) to be a target of genetic variants associated with serum progranulin levels. We aimed to identify potentially functional variants and characterize their role in regulation of PSRC1. Phylogenetic module complexity analysis (PMCA) prioritized four polymorphisms (rs12740374, rs629301, rs660240, rs7528419) altering transcription factor binding sites with an overall score for potential regulatory function of S(all) > 7.0. The effects of these variants on transcriptional activity and binding of transcription factors were tested by luciferase reporter and electrophoretic mobility shift assays (EMSA). In parallel, blood DNA promoter methylation of two regions was tested in subjects with a very high (N = 100) or a very low (N = 100) serum progranulin. Luciferase assays revealed lower activities in vectors carrying the rs629301-A compared with the C allele. Moreover, EMSA indicated a different binding pattern for the two rs629301 alleles, with an additional prominent band for the A allele, which was finally confirmed with the supershift for the Yin Yang 1 transcription factor (YY1). Subjects with high progranulin levels manifested a significantly higher mean DNA methylation (P < 1 × 10(−7)) in one promoter region, which was in line with a significantly lower PSRC1 mRNA expression levels in blood (P = 1 × 10(−3)). Consistently, rs629301-A allele was associated with lower PSRC1 mRNA expression (P < 1 × 10(−7)). Our data suggest that the progranulin-associated variant rs629301 modifies the transcription of PSRC1 through alteration of YY1 binding capacity. DNA methylation studies further support the role of PSRC1 in regulation of progranulin serum levels. KEY MESSAGES: PSRC1 (proline and serine rich coiled-coil 1) SNPs are associated with serum progranulin levels. rs629301 regulates PSRC1 expression by affecting Yin Yang 1 transcription factor (YY1) binding. PSRC1 is also epigenetically regulated in subjects with high progranulin levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00109-020-01942-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7399677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73996772020-08-13 Genetically programmed changes in transcription of the novel progranulin regulator Keller, Maria Gebhardt, Claudia Huth, Sandra Schleinitz, Dorit Heyne, Henrike Scholz, Markus Stumvoll, Michael Böttcher, Yvonne Tönjes, Anke Kovacs, Peter J Mol Med (Berl) Original Article ABSTRACT: Progranulin is a glycoprotein marking chronic inflammation in obesity and type 2 diabetes. Previous studies suggested PSRC1 (proline and serine rich coiled-coil 1) to be a target of genetic variants associated with serum progranulin levels. We aimed to identify potentially functional variants and characterize their role in regulation of PSRC1. Phylogenetic module complexity analysis (PMCA) prioritized four polymorphisms (rs12740374, rs629301, rs660240, rs7528419) altering transcription factor binding sites with an overall score for potential regulatory function of S(all) > 7.0. The effects of these variants on transcriptional activity and binding of transcription factors were tested by luciferase reporter and electrophoretic mobility shift assays (EMSA). In parallel, blood DNA promoter methylation of two regions was tested in subjects with a very high (N = 100) or a very low (N = 100) serum progranulin. Luciferase assays revealed lower activities in vectors carrying the rs629301-A compared with the C allele. Moreover, EMSA indicated a different binding pattern for the two rs629301 alleles, with an additional prominent band for the A allele, which was finally confirmed with the supershift for the Yin Yang 1 transcription factor (YY1). Subjects with high progranulin levels manifested a significantly higher mean DNA methylation (P < 1 × 10(−7)) in one promoter region, which was in line with a significantly lower PSRC1 mRNA expression levels in blood (P = 1 × 10(−3)). Consistently, rs629301-A allele was associated with lower PSRC1 mRNA expression (P < 1 × 10(−7)). Our data suggest that the progranulin-associated variant rs629301 modifies the transcription of PSRC1 through alteration of YY1 binding capacity. DNA methylation studies further support the role of PSRC1 in regulation of progranulin serum levels. KEY MESSAGES: PSRC1 (proline and serine rich coiled-coil 1) SNPs are associated with serum progranulin levels. rs629301 regulates PSRC1 expression by affecting Yin Yang 1 transcription factor (YY1) binding. PSRC1 is also epigenetically regulated in subjects with high progranulin levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00109-020-01942-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-07-03 2020 /pmc/articles/PMC7399677/ /pubmed/32620998 http://dx.doi.org/10.1007/s00109-020-01942-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Keller, Maria Gebhardt, Claudia Huth, Sandra Schleinitz, Dorit Heyne, Henrike Scholz, Markus Stumvoll, Michael Böttcher, Yvonne Tönjes, Anke Kovacs, Peter Genetically programmed changes in transcription of the novel progranulin regulator |
title | Genetically programmed changes in transcription of the novel progranulin regulator |
title_full | Genetically programmed changes in transcription of the novel progranulin regulator |
title_fullStr | Genetically programmed changes in transcription of the novel progranulin regulator |
title_full_unstemmed | Genetically programmed changes in transcription of the novel progranulin regulator |
title_short | Genetically programmed changes in transcription of the novel progranulin regulator |
title_sort | genetically programmed changes in transcription of the novel progranulin regulator |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399677/ https://www.ncbi.nlm.nih.gov/pubmed/32620998 http://dx.doi.org/10.1007/s00109-020-01942-7 |
work_keys_str_mv | AT kellermaria geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT gebhardtclaudia geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT huthsandra geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT schleinitzdorit geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT heynehenrike geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT scholzmarkus geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT stumvollmichael geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT bottcheryvonne geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT tonjesanke geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator AT kovacspeter geneticallyprogrammedchangesintranscriptionofthenovelprogranulinregulator |